AXA Framlington Biotech GBP Z Acc (FUND:B784NS1) - Fund price


Fund Report

AXA Framlington Biotech Fund GBP Z Acc

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)334.95 GBP
(22/05/2020)
Fund Size (mil)444.62 GBP
(30/04/2020)
Mkt Cap % 30/04/2020
FundCat
Giant8.276.64
Large42.6228.49
Medium23.8833.73
Small19.7728.70
Micro5.462.44
Valuations and Growth Rates 30/04/2020
FundCategory
Price / Earnings17.0022.19
Price/Book4.345.17
Price/Sales4.786.83
Price/Cash Flow12.4916.77
Dividend-Yield Factor0.500.33
Long-Term Projected Earnings Growth10.5916.06
Historical Earnings Growth27.0026.53
Sales Growth13.8211.92
Cash-Flow Growth17.6612.80
Book-Value Growth4.759.36

Asset Allocation % 30/04/2020

Asset Allocation
LongShortNetCat
Stocks94.910.0094.9195.22
Bonds0.000.000.000.04
Cash4.460.324.141.32
Other0.950.000.953.42
World Regions % 30/04/2020
FundCategory
Greater Europe8.108.73
United Kingdom0.911.77
Eurozone4.754.22
Europe - ex Euro2.442.74
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.00
Americas89.2586.53
United States89.2585.51
Canada0.001.02
Latin America0.000.00
Greater Asia2.654.74
Japan0.001.11
Australasia0.000.11
Asia - Developed0.000.31
Asia - Emerging2.653.21
Stock Sector Weightings % 30/04/2020
FundCategory
Cyclical0.000.23
Basic Materials--
Consumer Cyclical--
Financial Services-0.23
Real Estate--
Sensitive0.000.84
Communication Services--
Energy--
Industrials-0.23
Technology-0.61
Defensive100.0098.93
Consumer Defensive--
Healthcare100.0098.93
Utilities--

Top 10 Holdings30/04/2020

Assets in Top 10 Holdings %50.02
Total Number of Equity Holdings54
Total Number of Bond Holdings0
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
IncreaseAmgen Inc HealthcareUnited States7.82
IncreaseBiogen Inc HealthcareUnited States7.09
IncreaseRegeneron Pharmaceuticals Inc HealthcareUnited States6.45
IncreaseGilead Sciences Inc HealthcareUnited States6.07
IncreaseAlexion Pharmaceuticals Inc HealthcareUnited States4.80
IncreaseVertex Pharmaceuticals Inc HealthcareUnited States4.52
IncreaseSeattle Genetics Inc HealthcareUnited States3.72
IncreaseIncyte Corp HealthcareUnited States3.70
IncreaseBiomarin Pharmaceutical Inc HealthcareUnited States2.95
IncreaseAlnylam Pharmaceuticals Inc HealthcareUnited States2.90
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.